Thermo King has expanded its portfolio of ultra-low temperature temporary storage solutions to the unique requirements of global pharmaceutical companies developing COVID-19 vaccines.
Pharmaceutical companies in final-stage clinical trials anticipate they will require strict temperature controls to safeguard their products – down to temperatures as low as -70°C.
The manufacturer’s solutions can enable these companies and their distributors to ensure the efficacy of their products through the entire cold chain – from air transport to marine, rail, trailer, last-mile delivery and at storage points along the way.
You need a free subscription to read the entire article.
Login if you have already subscribed.
Subscribe
Subscribe for FREE and gain access to all our content.
More than 5000+ articles.